Soini EJ et al. |
Cost-utility of first-line actinic keratosis treatments in Finland. |
2015 |
Adv Ther |
pmid:26006101
|
|
|
|
|
pmid:26055975
|
Stockfleth E et al. |
New Topical Treatment Options for Actinic Keratosis: A Systematic Review. |
2016 |
Acta Derm. Venereol. |
pmid:26068001
|
Freiberger SN et al. |
Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2. |
2015 |
Mol. Cancer Ther. |
pmid:26116359
|
|
|
|
|
pmid:26130156
|
Jiang G et al. |
Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation. |
2015 |
PLoS Pathog. |
pmid:26225771
|
|
|
|
|
pmid:26227007
|
|
|
|
|
pmid:26258811
|
|
|
|
|
pmid:26267725
|
Pellacani G et al. |
A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body. |
2015 |
J Eur Acad Dermatol Venereol |
pmid:26300464
|